Schedule 13G ownership disclosure
CARA THERAPEUTICS INC
Security class unavailable · CUSIP: 140755109
Event date: 2014-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,668,057
- Percent of class
- 11.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001171520-15-000078
- Form type
- SC 13G
- Filer
- Tvardi Therapeutics, Inc.
- CIK
- CIK 1346830
- Filed
- Jan 29, 2015
- Reporting period
- Dec 31, 2014
- Description
- Schedule 13G beneficial ownership